Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats

Nature
O ReinerD H Ledbetter

Abstract

Lissencephaly (agyria-pachygyria) is a human brain malformation manifested by a smooth cerebral surface and abnormal neuronal migration. Identification of the gene(s) involved in this disorder would facilitate molecular dissection of normal events in brain development. Type 1 lissencephaly occurs either as an isolated abnormality or in association with dysmorphic facial appearance in patients with Miller-Dieker syndrome. About 15% of patients with isolated lissencephaly and more than 90% of patients with Miller-Dieker syndrome have microdeletions in a critical 350-kilobase region in chromosome 17p13.3 (ref. 6). These deletions are hemizygous, so haplo-insufficiency for a gene in this interval is implicated. Here we report the cloning of a gene (LIS-1, lissencephaly-1) in 17p13.3 that is deleted in Miller-Dieker patients. Non-overlapping deletions involving either the 5' or 3' end of the gene were found in two patients, identifying LIS-1 as the disease gene. The deduced amino-acid sequence shows significant homology to beta-subunits of heterotrimeric G proteins, suggesting that it could possibly be involved in a signal transduction pathway crucial for cerebral development.

References

Sep 23, 1976·The New England Journal of Medicine·S H Orkin, D G Nathan
Feb 21, 1992·Cell·C A KeleherA D Johnson
May 10, 1991·Science·M I SimonN Gautam
Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·F GuillemotC Auffray
Jan 1, 1987·Annual Review of Biochemistry·A G Gilman
Mar 11, 1988·Nucleic Acids Research·H S Bilofsky, C Burks
Feb 1, 1987·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·P G Barth
Jan 1, 1993·Cell·H R Bourne, R Nicoll
Oct 1, 1963·Neurology·J Q MILLER

❮ Previous
Next ❯

Citations

Jul 13, 1999·Microscopy Research and Technique·I BlümckeO D Wiestler
Mar 29, 2000·Journal of Cellular Physiology·M BoccellinoG Camussi
Jul 19, 2000·Mental Retardation and Developmental Disabilities Research Reviews·C A Walsh
Jul 19, 2000·Mental Retardation and Developmental Disabilities Research Reviews·S L Pomeroy, J Y Kim
Dec 7, 2000·Mental Retardation and Developmental Disabilities Research Reviews·P A Schwartzkroin, C A Walsh
Feb 16, 1999·Annals of Neurology·G D Clark, J L Noebels
Sep 13, 2001·Mental Retardation and Developmental Disabilities Research Reviews·J G Gleeson
Feb 1, 1995·Mammalian Genome : Official Journal of the International Mammalian Genome Society·A Kurtz, A Zimmer
Jan 1, 1994·Journal of Inherited Metabolic Disease·D Donnai
Sep 1, 1995·Somatic Cell and Molecular Genetics·M PéterfyL Takécs
Jul 1, 1994·Human Genetics·A MantelP Landrieu
Aug 31, 2000·Molecular Neurobiology·O Reiner
May 26, 2006·Experimental Brain Research·Renzo Guerrini, Carla Marini
Dec 25, 2012·Surgical and Radiologic Anatomy : SRA·Zarina A AzizG G Sharath Kumar
Jul 17, 2007·Mammalian Genome : Official Journal of the International Mammalian Genome Society·David A Keays
Nov 1, 1996·Mammalian Genome : Official Journal of the International Mammalian Genome Society·H O SweetM T Davisson
Mar 2, 2005·Acta Neuropathologica·MacLean PancoastJeffrey A Golden
Feb 4, 2006·Acta Neuropathologica·Volney L SheenChristopher A Walsh
Nov 4, 2010·Acta Neuropathologica·Gaëlle FriocourtAnnie Laquerrière
Aug 14, 2003·Current Neurology and Neuroscience Reports·Volney L Sheen, Christopher A Walsh
Jan 12, 2011·Current Neurology and Neuroscience Reports·Judy S Liu
Nov 30, 2000·Current Treatment Options in Neurology·P B Crino, K Chou
Mar 31, 2009·Molecular Neurobiology·Orly Reiner, Tamar Sapir
Jul 1, 1994·Journal of the Neurological Sciences·U MüllerA Köhler
May 6, 1994·Cell·M Liscovitch, L C Cantley
Jun 1, 1994·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·W E KaufmannP F Worley
Jan 1, 1995·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·B DallapiccolaG Novelli
Mar 17, 2004·Biochimica Et Biophysica Acta·Li-Huei TsaiJonathan Cruz
Oct 16, 2003·Trends in Biochemical Sciences·Nobutaka Hirokawa, Reiko Takemura
Nov 16, 2002·Prostaglandins & Other Lipid Mediators·Hiroyuki Arai
Jul 4, 1998·Brain Research. Brain Research Reviews·T Curran, G D'Arcangelo
Jul 25, 2000·Trends in Neurosciences·J G Gleeson, C A Walsh
Aug 17, 2001·Trends in Neurosciences·R J LeventerW B Dobyns
Oct 29, 2002·Biochimica Et Biophysica Acta·Heidi StöhrBernhard H F Weber
Aug 26, 1998·Drug and Alcohol Dependence·P Levitt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.